| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2003 , Vol 45 , Num 1
2-(3-Acetyloxy-2- Naphthyl)-4-Acetyl-5-Phenyl-1,3,4-0xadiazoline Suppresses Pentylenetetrazol-Induced Convulsive and Oxidative Activity on Mice